# A Study of Loco-Regional Liposomal Bupivacaine Injection

> **NCT05992896** · PHASE4 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DRUG:** Bupivacaine liposome
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05992896
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-09-26
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-06-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Lack of funds
- **Last updated:** 2025-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05992896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05992896, "A Study of Loco-Regional Liposomal Bupivacaine Injection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05992896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*